NCT01007357

Brief Summary

This project will facilitate the optimization of body MR imaging at 3 Tesla.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2009

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 4, 2009

Completed
1 month until next milestone

Study Start

First participant enrolled

December 15, 2009

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2015

Completed
Last Updated

July 14, 2023

Status Verified

July 1, 2023

Enrollment Period

5.5 years

First QC Date

October 28, 2009

Last Update Submit

July 12, 2023

Conditions

Diffuse and Focal Abnormalities of the Liver and Pancreas

Outcome Measures

Primary Outcomes (1)

  • Optimizing body MR imaging sequences

    Healthy volunteers will be used to obtain optimized body MR imaging sequences that will then be used to evaluate MR imaging sequences of subjects with underlying disorders.

    2 years

Study Arms (1)

Body MRI healthy volunteers

OTHER

Body MRI to optimize sequences in healthy individuals and in disorder subjects

Device: Body MR imaging

Interventions

Body MR imagingDEVICE

Body MR imaging will be performed to optimize sequences

Also known as: Body MR imaging performed to optimize sequences
Body MRI healthy volunteers

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects between ages of 19 and 65
  • Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
  • Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)

You may not qualify if:

  • Inability to provide informed consent
  • A medical or contraindications that will prevent subjects from having a MRI
  • Subjects with severe renal dysfunction or patients on dialysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Nebraska Medical Center

Omaha, Nebraska, 68198-1045, United States

Location

University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

Location

Study Officials

  • Shahid Hussain, MD

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2009

First Posted

November 4, 2009

Study Start

December 15, 2009

Primary Completion

June 30, 2015

Study Completion

June 30, 2015

Last Updated

July 14, 2023

Record last verified: 2023-07

Locations

US(2)